Stem Cell Therapy for Fibromyalgia in Istanbul, Turkey

The case review, the laboratory work your file calls for, the number of infusions and the monitoring during your stay are priced as separate items, because not every case needs the same list. Our patient coordination team puts the itemized plan in writing before travel is booked, says plainly what it does not include, and confirms which follow-up contact after you fly home is part of the plan.

The reasoning behind it is sound and worth stating clearly: these cells are studied for immune and inflammatory signalling, and that is where current research into amplified pain is looking. Clinical work in fibromyalgia specifically is at an early stage, and people respond differently, which is why your plan is written as goals with a measurement attached rather than as an expected result. Our medical team would rather say that to you before you travel than afterwards.

It follows your plan - the assessment, the number of infusions, the observation period after each one and any rest days built in around them. Our patient coordination team confirms the dates, the daily timings and the total length of the visit in writing before you book flights, so you can judge the travel against a bad week rather than a good one.

Central sensitisation describes a nervous system that has become efficient at producing pain, and nothing in this plan is aimed at overriding it - the target is the inflammatory and immune signalling around it. Your duloxetine, pregabalin, amitriptyline or whatever you are established on continues under the doctor who prescribed it, and nothing is reduced for our plan without that doctor's agreement; our medical team reviews timing and interactions before treatment. Pacing, graded activity and the sleep work you have put in keep doing their job and keep their own credit for it.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.